Cancer survival rates are at a record high and around 7,000 more people are surviving cancer after successful treatment on the National Health Service compared to three years ago. However, there is more that we can do. NHS England is leading the implementation of the recommendations of the independent Cancer Taskforce to save a further 30,000 lives by 2020.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4545", "label" : {"_value" : "Biography information for Lord O'Shaughnessy"} } , "answeringMemberPrinted" : {"_value" : "Lord O'Shaughnessy"} , "dateOfAnswer" : {"_value" : "2017-07-31", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2017-07-31T13:27:52.883Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health"} , "answeringDeptSortName" : {"_value" : "Health"} , "date" : {"_value" : "2017-07-19", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Cancer: Mortality Rates"} , "houseId" : {"_value" : "2"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"} } ], "questionText" : "Her Majesty's Government what is their assessment of the findings by Integrating the Healthcare Enterprise in its report, Comparator report on patient access to cancer medicines in Europe Revisited, that UK five-year survival outcomes for cancer lag behind the European average for nine out of ten cancers.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/2024", "label" : {"_value" : "Biography information for Lord Hunt of Kings Heath"} } , "tablingMemberPrinted" : [{"_value" : "Lord Hunt of Kings Heath"} ], "uin" : "HL1056"} , {"_about" : "http://data.parliament.uk/resources/753942", "AnsweringBody" : [{"_value" : "Department of Health"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/753942/answer", "answerText" : {"_value" : "
Ministers routinely meet nursing leaders and discuss a range of issues, including recruitment and retention of nurses and midwives.<\/p>
<\/p>
The Government remains committed to reforming nursing, midwifery and allied health pre-registration education and increasing the number of places available for students so that two in three nursing applicants are no longer turned down for a place; at the same time ensuring these students have more money available to them while they study.<\/p>
<\/p>
Health Education England is confident that the National Health Service will have the required number of students it needs starting courses this year and will continue to work with the education sector to deliver these reforms successfully for the longer term.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4545", "label" : {"_value" : "Biography information for Lord O'Shaughnessy"} } , "answeringMemberPrinted" : {"_value" : "Lord O'Shaughnessy"} , "dateOfAnswer" : {"_value" : "2017-07-31", "_datatype" : "dateTime"} , "groupedQuestionUIN" : {"_value" : "HL1090"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2017-07-31T14:34:31Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health"} , "answeringDeptSortName" : {"_value" : "Health"} , "date" : {"_value" : "2017-07-19", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Nurses: Training"} , "houseId" : {"_value" : "2"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"} } ], "questionText" : "Her Majesty's Government what discussions they have had with (1) the Royal College of Nursing, (2) the Royal College of Midwives, and (3) UNISON, as a consequence of the fall since 2016 reported by UCAS in the number of applications to universities to study for nursing degrees.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/2507", "label" : {"_value" : "Biography information for Lord MacKenzie of Culkein"} } , "tablingMemberPrinted" : [{"_value" : "Lord MacKenzie of Culkein"} ], "uin" : "HL1089"} , {"_about" : "http://data.parliament.uk/resources/753944", "AnsweringBody" : [{"_value" : "Department of Health"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/753944/answer", "answerText" : {"_value" : "
Ministers routinely meet nursing leaders and discuss a range of issues, including recruitment and retention of nurses and midwives.<\/p>
<\/p>
The Government remains committed to reforming nursing, midwifery and allied health pre-registration education and increasing the number of places available for students so that two in three nursing applicants are no longer turned down for a place; at the same time ensuring these students have more money available to them while they study.<\/p>
<\/p>
Health Education England is confident that the National Health Service will have the required number of students it needs starting courses this year and will continue to work with the education sector to deliver these reforms successfully for the longer term.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4545", "label" : {"_value" : "Biography information for Lord O'Shaughnessy"} } , "answeringMemberPrinted" : {"_value" : "Lord O'Shaughnessy"} , "dateOfAnswer" : {"_value" : "2017-07-31", "_datatype" : "dateTime"} , "groupedQuestionUIN" : {"_value" : "HL1089"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2017-07-31T14:34:31.047Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health"} , "answeringDeptSortName" : {"_value" : "Health"} , "date" : {"_value" : "2017-07-19", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Nurses: Training"} , "houseId" : {"_value" : "2"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"} } ], "questionText" : "Her Majesty's Government what progress has been made to date in implementing their plan to provide 10,000 additional nursing student places by 2020; and how much additional funding has been provided to universities as part of this plan.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/2507", "label" : {"_value" : "Biography information for Lord MacKenzie of Culkein"} } , "tablingMemberPrinted" : [{"_value" : "Lord MacKenzie of Culkein"} ], "uin" : "HL1090"} , {"_about" : "http://data.parliament.uk/resources/753958", "AnsweringBody" : [{"_value" : "Department of Health"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/753958/answer", "answerText" : {"_value" : "
The Government is fully aware of the importance of molybdenum-99 and the reliance on this medical radioisotope for diagnostic procedures in the National Health Service. The United Kingdom\u2019s ability to import medical isotopes from Europe and the rest of the world will not be affected by withdrawal from Euratom. It is in everyone\u2019s interest to not disrupt the timely access of treatment to patients and to ensure that cross-border trade with the European Union and Euratom is as frictionless as possible.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4545", "label" : {"_value" : "Biography information for Lord O'Shaughnessy"} } , "answeringMemberPrinted" : {"_value" : "Lord O'Shaughnessy"} , "dateOfAnswer" : {"_value" : "2017-07-31", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2017-07-31T13:38:56.527Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health"} , "answeringDeptSortName" : {"_value" : "Health"} , "date" : {"_value" : "2017-07-19", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Radioisotopes: Imports"} , "houseId" : {"_value" : "2"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"} } ], "questionText" : "Her Majesty's Government (1) what assessment they have made of the potential impact of not reaching agreement with the EU by April 2019 on the supply of the radioisotope molybdenum-99 used to produce technetium-99m which is required for over 80 per cent of diagnostic medicine procedures in the UK; (2) what assessment they have made of the potential impact of delays or disruption to the supply of diagnostic medicine procedures that may result; and (3) what contingency plans they have put in place to mitigate such delays or disruption to that supply after Brexit.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4286", "label" : {"_value" : "Biography information for Lord Mendelsohn"} } , "tablingMemberPrinted" : [{"_value" : "Lord Mendelsohn"} ], "uin" : "HL1104"} ], "itemsPerPage" : 10, "page" : 0, "startIndex" : 1, "totalResults" : 4, "type" : ["http://purl.org/linked-data/api/vocab#ListEndpoint", "http://purl.org/linked-data/api/vocab#Page"]} }